SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-017113
Filing Date
2021-05-13
Accepted
2021-05-13 07:00:33
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10024337_10q.htm 10-Q 500861
2 EXHIBIT 31.1 brhc10024337_ex31-1.htm EX-31.1 13340
3 EXHIBIT 31.2 brhc10024337_ex31-2.htm EX-31.2 13047
4 EXHIBIT 32.1 brhc10024337_ex32-1.htm EX-32.1 5673
5 EXHIBIT 32.2 brhc10024337_ex32-2.htm EX-32.2 5382
12 image00001.jpg GRAPHIC 32594
  Complete submission text file 0001140361-21-017113.txt   2903666

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdsb-20210331.xml EX-101.INS 381788
7 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20210331.xsd EX-101.SCH 30543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20210331_cal.xml EX-101.CAL 29370
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20210331_def.xml EX-101.DEF 112784
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20210331_lab.xml EX-101.LAB 447600
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20210331_pre.xml EX-101.PRE 234478
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 21917140
SIC: 2834 Pharmaceutical Preparations